Previous Article | Next Article ![]()
Infect. Immun., 05 1995, 1955-1959, Vol 63, No. 5
A Malik, R Houghten, G Corradin, S Buus, JA Berzofsky and SL Hoffman
Class I-restricted CD8+ cytotoxic T lymphocytes (CTL) against the
circumsporozoite protein (CSP) protect mice against the rodent malaria
parasite, Plasmodium yoelii, and vaccines designed to produce protective
CTL against the P. falciparum CSP (PfCSP) are under development. Humans and
B10.BR (H-2k) mice have been shown to have CD8+ CTL activity against a
23-amino-acid region of the PfCSP (residues 368 to 390 from the PfCSP 7G8
sequence) that is too long to bind directly to class I major
histocompatibility complex molecules. To identify within this 23-amino-acid
peptide a shorter peptide that binds to an H- 2k class I major
histocompatibility molecule, a primarily CD8+ (97.8%) T-cell line (PfCSP
TCL.1) was produced by immunizing B10.BR mice with recombinant vaccinia
virus expressing the PfCSP and stimulating in vitro spleen cells from these
immunized mice with L cells transfected with the PfCSP gene (LPF cells).
PfCSP TCL.1 lysed LPF cells and L cells pulsed with peptide PfCSP 7G8
368-390. When 15 overlapping nonamer peptides spanning the 368 to 390
sequence were tested, only one peptide, PfCSP 7G8 375-383 (Y E N D I E K K
I), which includes an H-2Kk- binding motif, E at amino acid residue 2, and
I at residue 9, sensitized targets for lysis by PfCSP TCL.1. Furthermore, a
10(3)- to 10(4)-fold lower concentration of the nonamer than that of the
23-amino- acid peptide was required to sensitize target cells for lysis by
PfCSP TCL.1. Presentation by H-2Kk was demonstrated by using 3T3 fibroblast
cells transfected with the murine H-2Kk or H-2Dk genes, and only the H- 2Kk
transfectants were lysed by PfCSP TCL.1 after incubation with peptide PfCSP
7G8 375-383. Binding to H-2Kk was confirmed by competitive inhibition of
binding of labelled peptides to affinity- purified Kk molecules.
Substitution of the anchor amino acid residue, E, at position 2 with A
dramatically reduced binding to Kk and eliminated the capacity of the
peptide to sensitize target cells for killing. Variation of non-anchor
residues did not markedly reduce binding to Kk but in some cases eliminated
the capacity of the peptide to sensitize targets for cytolysis by PfCSP
TCL.1, presumably by eliminating T-cell receptor-binding sites. These data
suggest that similar studies with human T cells will be required for
optimal development of peptide-based vaccines designed to produce
protective class I-restricted CD8+ CTL against the PfCSP in humans.
Copyright © 1995, American Society for Microbiology
Identification of a nonameric H-2Kk-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein
Malaria Program, Naval Medical Research Institute, Bethesda, Maryland 20889-5607, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|